Skip to main content
Equibles

ALGERT GLOBAL LLC

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1275218 SAN FRANCISCO, CA
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,020,897
+$4,043,215 QoQ
Shares Held
389,964
-9.0% QoQ
Ownership
0.396%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#50
of 311 holders
Holding Since
Sep 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. RARE ranks #15 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PCVX
Vaxcyte, Inc.
 515,343 $29,956,888
2 ROIV
Roivant Sciences Ltd.
 845,118 $29,908,726
3 XENE
Xenon Pharmaceuticals Inc.
 419,773 $25,337,498
4 CLDX
Celldex Therapeutics, Inc.
 647,836 $24,105,977
5 AXSM
Axsome Therapeutics, Inc.
 95,335 $23,335,147
6 SNDX
Syndax Pharmaceuticals Inc
 1,051,465 $22,985,024
7 MRNA
Moderna, Inc.
 274,820 $19,245,644
8 MLYS
Mineralys Therapeutics, Inc.
 649,027 $17,510,748

All Filings in RARE

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,020,897 389,964
2026-03-31 $8,977,682 428,529
2025-12-31 $5,042,336 219,232
2025-09-30 $9,674,720 321,633
2025-06-30 $4,230,376 116,347
2025-03-31 $4,718,887 130,320
2024-12-31 $3,483,101 82,793
2024-09-30 $4,105,256 73,902
2024-06-30 $2,068,234 50,322
2024-03-31 $1,147,173 24,570
2023-12-31 $1,174,937 24,570
2023-09-30 $789,291 22,140
2023-06-30 $1,238,590 26,850
2023-03-31 $1,554,276 38,760
2022-03-31 $222,289 3,061
2021-12-31 $374,452 4,453
2021-09-30 $563,958 6,253